-
New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer
Patients with lung cancer will soon be able to receive immunotherapy as first-line treatment on an experimental…
-
When Is a Spot Not a Spot?
A ten-year effort to optimize a ubiquitous laboratory assay finally pays off.
-
Immunotherapy: 5 Ways to Stop Cancer
The Cancer Research Institute has created a series of short, animated videos that explain the basics of…
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.
-
ASCO 2015: Report from Day 2
The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.
-
AACR 2015: Report from Day 5
Some lesser-known cell types in the immune response to cancer were discussed on the meeting's final day.
-
AACR 2015: Report from Day 4
Spotlight on CAR T cell therapy.
